Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dendritic cells and their role in tumor immunosurveillance.
Strioga M, Schijns V, Powell DJ Jr, Pasukoniene V, Dobrovolskiene N, Michalek J. Strioga M, et al. Among authors: schijns v. Innate Immun. 2013 Feb;19(1):98-111. doi: 10.1177/1753425912449549. Epub 2012 Jun 25. Innate Immun. 2013. PMID: 22732734 Free article. Review.
Therapeutic dendritic cell-based cancer vaccines: the state of the art.
Strioga MM, Felzmann T, Powell DJ Jr, Ostapenko V, Dobrovolskiene NT, Matuskova M, Michalek J, Schijns VE. Strioga MM, et al. Among authors: schijns ve. Crit Rev Immunol. 2013;33(6):489-547. doi: 10.1615/critrevimmunol.2013008033. Crit Rev Immunol. 2013. PMID: 24266347 Review.
Tumor lysate-loaded Bacterial Ghosts as a tool for optimized production of therapeutic dendritic cell-based cancer vaccines.
Dobrovolskienė N, Pašukonienė V, Darinskas A, Kraśko JA, Žilionytė K, Mlynska A, Gudlevičienė Ž, Mišeikytė-Kaubrienė E, Schijns V, Lubitz W, Kudela P, Strioga M. Dobrovolskienė N, et al. Among authors: schijns v. Vaccine. 2018 Jul 5;36(29):4171-4180. doi: 10.1016/j.vaccine.2018.06.016. Epub 2018 Jun 9. Vaccine. 2018. PMID: 29895501
Outer membrane vesicle-based intranasal vaccines.
Van der Ley P, Schijns VE. Van der Ley P, et al. Among authors: schijns ve. Curr Opin Immunol. 2023 Oct;84:102376. doi: 10.1016/j.coi.2023.102376. Epub 2023 Aug 18. Curr Opin Immunol. 2023. PMID: 37598549 Free article. Review.
A Prospective, Cohort Study of SITOIGANAP to Treat Glioblastoma When Given in Combination With Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Nivolumab or Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Pembrolizumab in Patients Who Failed Prior Treatment With Surgical Resection, Radiation, and Temozolomide.
Bota DA, Taylor TH, Lomeli N, Kong XT, Fu BD, Schönthal AH, Singer S, Blumenthal DT, Senecal FM, Linardou H, Rokas E, Antoniou DG, Schijns VEJC, Chen TC, Elliot J, Stathopoulos A. Bota DA, et al. Among authors: schijns vejc. Front Oncol. 2022 Jun 28;12:934638. doi: 10.3389/fonc.2022.934638. eCollection 2022. Front Oncol. 2022. PMID: 35837107 Free PMC article.
Rational Vaccine Design in Times of Emerging Diseases: The Critical Choices of Immunological Correlates of Protection, Vaccine Antigen and Immunomodulation.
Schijns V, Majhen D, van der Ley P, Thakur A, Summerfield A, Berisio R, Nativi C, Fernández-Tejada A, Alvarez-Dominguez C, Gizurarson S, Zamyatina A, Molinaro A, Rosano C, Jakopin Ž, Gursel I, McClean S. Schijns V, et al. Pharmaceutics. 2021 Apr 6;13(4):501. doi: 10.3390/pharmaceutics13040501. Pharmaceutics. 2021. PMID: 33917629 Free PMC article. Review.
Modulation of immune responses using adjuvants to facilitate therapeutic vaccination.
Schijns V, Fernández-Tejada A, Barjaktarović Ž, Bouzalas I, Brimnes J, Chernysh S, Gizurarson S, Gursel I, Jakopin Ž, Lawrenz M, Nativi C, Paul S, Pedersen GK, Rosano C, Ruiz-de-Angulo A, Slütter B, Thakur A, Christensen D, Lavelle EC. Schijns V, et al. Immunol Rev. 2020 Jul;296(1):169-190. doi: 10.1111/imr.12889. Epub 2020 Jun 28. Immunol Rev. 2020. PMID: 32594569 Free PMC article. Review.
73 results